Citigroup
CPAH

Citigroup’s Counterpath Corp CPAH Stock Holding History

Citigroup’s Portfolio CPAH Stock Details CPAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-40
Closed – – 7684
2014
Q4 		$0 Buy
+40
New +$334 ﹤0.01% 7532

Other funds holding CPAH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup's CPAH Position: Q1 2015 in Review

Citigroup sold out of Counterpath Corp (CPAH) in Q1 2015, closing a stake of 40 shares.

Citigroup first reported a position in CPAH in Q4 2014 and held it in 1 quarter. The position peaked at $0 in Q4 2014. 4 funds tracked by Wall St. Rank hold CPAH as of Q1 2015.

  • Citigroup reported no remaining Counterpath Corp position as of Q1 2015 after selling out during the quarter.
  • Citigroup sold 40 Counterpath Corp shares in Q1 2015.
  • Citigroup first reported a position in Counterpath Corp in Q4 2014 and held it in 1 quarter.
  • Citigroup's Counterpath Corp position peaked at $0 in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Counterpath Corp as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.